论文部分内容阅读
1976年德国学者Tauchert首先提出潘生丁试验,并肯定了其在冠心病诊断中的价值。但由于试验中常规导联记录部位的局限性,使部份病例在注射潘生丁后出现的缺血性ST段改变不能被记录到,以致产生假阴性结果。为进一步提高潘生丁试验的阳性检出率,本文设计了潘生丁试验心前区30导联标测法。现将38例用此方法进行观测的结果报告如下。资料与方法一、分组 (一)冠心病组:按世界卫生组织冠心
Tauchert German scholars in 1976 first proposed dipyridamole test, and confirmed its value in the diagnosis of coronary heart disease. However, due to the limitations of conventional lead recordings in the trial, ischemic ST segment changes in some cases after injection of dipyridamole could not be recorded, resulting in false negative results. In order to further improve the positive detection rate of dipyridamole test, this paper designed 30-lead dipyridamole test preclinical mapping. Now 38 cases of this method to observe the results reported below. Materials and methods A group (a) coronary heart disease group: according to the World Health Organization coronary heart